Becton Dickinson and CompanyMarket growth driven by rising chronic diseases and hospitalizations increases demand for IV devices, benefiting BD as a leading player.
The global IV equipment market is projected to grow from USD 17.82 billion in 2026 to USD 23.92 billion by 2031, at a compound annual growth rate of 6.1%, according to a new report added to ResearchAndMarkets.com. Growth is driven by rising chronic disease prevalence, increasing hospitalizations, and a shift toward home-based and outpatient care, with technological advancements such as needle-free connectors and smart infusion pumps boosting adoption. North America leads the market due to robust healthcare infrastructure and high adoption of medical technologies. Key players include Becton, Dickinson and Company, B. Braun SE, and Fresenius SE.
Becton Dickinson and CompanyMarket growth driven by rising chronic diseases and hospitalizations increases demand for IV devices, benefiting BD as a leading player.
Fresenius SE & Co. KGaAMarket growth driven by rising chronic diseases and hospitalizations increases demand for IV devices, benefiting Fresenius as a leading player.